BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 177705)

  • 1. Indirect haemagglutination reaction (LH)-the method of choice for the detection of anamnestic antibodies to varicella - zoster (VZ) virus.
    Trlifajová J; Ryba M; Jelĭnek J
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):101-6. PubMed ID: 177705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay for antibodies in varicella-zoster virus serology.
    Trlifajova J; Pokorný J; Nĕmecek V; Ryba M
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):332-9. PubMed ID: 231068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella-zoster antibodies in adult patient with haemoblastoses.
    Trlifajová J; Lukásová M; Janele J; Jelínek J
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):413-6. PubMed ID: 180728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect haemagglutination reaction with varicella-zoster virus antigen.
    Trlifajová J; Pokorný J; Ryba M; Strízová V
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):26-36. PubMed ID: 4350836
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of persistence of maternal antibodies to varicella-zoster virus by indirect haemagglutination, with result control by radioimmunoassay.
    Trlifajová J; Pokorný J; Svandovă E; Ryba M
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(1):65-73. PubMed ID: 6282961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A laboratory study of age-related varicella incidence and prevalence in the Czech Socialist Republic.
    Trlifajová J; Svandová E; Pokorný J; Pokorný J
    Acta Virol; 1989 Mar; 33(2):183-7. PubMed ID: 2569816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility to varicella-zoster virus in Thai children and young adults.
    Kositanont U; Wasi C; Oonsombat P; Suvatte V; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):414-20. PubMed ID: 3006266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella morbidity in Czechoslovakia.
    Trlifajová J; Svandová E; Havrlantová M; Galetková A
    J Hyg Epidemiol Microbiol Immunol; 1980; 24(2):192-9. PubMed ID: 6251130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the properties of an experimental batch of zoster immune gammaglobulin (ZIG).
    Trlifajová J; Petera A; Ryba M; Pokorný J
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(1):42-50. PubMed ID: 93127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of varicella-zoster antibody by immune adherence hemagglutination test.
    Kositanont U; Suvatte V; Wasi C; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):342-7. PubMed ID: 6098021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of varicella zoster virus in pregnant patients].
    Sauerbrei A; Sonntag S; Wutzler P
    Zentralbl Gynakol; 1990; 112(4):223-6. PubMed ID: 2159681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The age distribution of neutralizing antibodies against varicella-zoster virus in healthy individuals.
    Ozaki T; Nagai H; Kimura T; Ichikawa T; Suzuki S; Kito H; Asano Y
    Biken J; 1980 Mar; 23(1):9-14. PubMed ID: 6254500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to varicella-zoster in the aged.
    Burke BL; Steele RW; Beard OW; Wood JS; Cain TD; Marmer DJ
    Arch Intern Med; 1982 Feb; 142(2):291-3. PubMed ID: 6277260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.
    Perella D; Fiks AG; Jumaan A; Robinson D; Gargiullo P; Pletcher J; Forke CM; Schmid DS; Renwick M; Mankodi F; Watson B; Spain CV
    Pediatrics; 2009 May; 123(5):e820-8. PubMed ID: 19403475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The study of the occurrence of precipitation antibodies to varicella-zoster (VZ) virus in healthy and sick children up to one year of age in relation to their transplacental transfer.
    Trlifajová J; Hájková S; Ryba M; Sourek J; Svandová E; Seeman J
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(4):486-92. PubMed ID: 4344650
    [No Abstract]   [Full Text] [Related]  

  • 16. Seroepidemiologic aspects of varicella zoster virus infections in an Israeli Jewish population.
    Leventon-Kriss S; Yoffe R; Rannon L; Modan M
    Isr J Med Sci; 1978 Jul; 14(7):766-70. PubMed ID: 210147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid assay for antibodies to Varicella-Zoster virus (VZV) using a VZV-HEM preparation.
    Trlifajová J; Kyselová M; Brůcková M; Svandová E
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(2):171-6. PubMed ID: 3013988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement fixing antibody to varicella-zoster virus in different age groups and after zoster.
    Moschen ME; Peserico A; Trivello R
    Boll Ist Sieroter Milan; 1977 Mar; 56(1):70-3. PubMed ID: 193530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of precipitins to varicella-zoster virus in different age groups.
    Trlifajová J; Sourek J
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(3):366-9. PubMed ID: 4342923
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-mediated immunity to varicella-zoster virus as assessed by the migration inhibition test.
    Trlifajová J; Svejcar J; Svandová E; Ryba M; Pekárek J
    Acta Virol; 1980 Dec; 24(6):406-14. PubMed ID: 6111201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.